|
Oct 25
|
GSK (GSK) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Oct 25
|
New Data for AREXVY, GSK’s RSV Vaccine, Show Potential to Help Protect Adults Aged 50 to 59 at Increased Risk for RSV Disease
|
|
Aug 29
|
Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations
|
|
Aug 26
|
3 Growth Stocks to Ride the Coming Bull Market in Style
|
|
Aug 26
|
Ken Fisher’s Top 15 Healthcare Stock Picks
|
|
Jul 5
|
Moderna announces China investment as country opens doors to foreign pharma
|
|
Jun 30
|
First trial over Zantac cancer claims set for November
|
|
May 18
|
Top Pharmaceutical Stocks for Q2 2023
|
|
May 18
|
UPDATE 2-US FDA panel backs Pfizer's maternal RSV vaccine for protecting infants
|
|
May 18
|
25 Most Prescribed Medication in the World
|
|
May 18
|
US FDA advisers to discuss Pfizer's maternal RSV vaccine
|